You are here

Continuing Education Credit

National Guidelines for a Novel Therapy: Update on Clinical Trials and Experience Using Consensus Panel Recommendations for Incorporating Omalizumab into Asthma Management

Mark J. Baumel, MD, Lawrence Du Buske, MD, Stanley J. Szefler, MD, Lanny Rosenwasser, MD, and David B. Nash, MD, MBA
PDF version: 
A panel of experts in allergies and pulmonology discuss the appropriate use of omalizumab with respect to current asthma guidelines and review the drug’s ability to improve symptoms, reduce exacerbations, and decrease patients’ use of health care resources.